NovAccess Global Inc.
CIK: 0001039466
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation CO
Business Address 8584 E. WASHINGTON STREET, NO. 127, CHAGRIN FALLS, OH, 44023
Mailing Address 8584 E. WASHINGTON STREET, NO. 127, CHAGRIN FALLS, OH, 44023
Phone (213) 642-9268
Fiscal Year End 0930
EIN 841384159
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | January 14, 2026 | View on SEC |
Annual Reports
10-K January 14, 2026
- Developing novel immunotherapies for brain tumor patients, specifically glioblastoma, a high-need area.
- Holds an exclusive patent license for StemVax Glioblast (SVX-GB/TLR-AD1) from Cedars-Sinai Medical Center.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.